-
The global GLP-1R agonist market rapidly expands
PharmaSources/1℃
May 29, 2019
According to my statistical data, the global diabetes market size was around USD40 billion during 2008-2018, wherein, insulin products accounted for about 50%.
-
Polyethylene Glycol Loxenatide! The First Chinese-produced Long-acting GLP-1R Agonist
PharmaSources/1℃
May 29, 2019
The blockbuster diabetes product: long-acting GLP-1 receptor agonist polyethylene glycol loxenatide (trade name: Fulaimei) of Hansoh Pharmaceutical has been marketed on May 7, 2019
-
New Gene Variants for Type 2 Diabetes Found
drugs
May 24, 2019
New Gene Variants for Type 2 Diabetes Found.
-
Open Communication Helps Teens Manage Type 1 Diabetes
drugs
May 24, 2019
It's a simple concept, but new research reinforces the idea: Teens with type 1 diabetes benefit when they feel their concerns have been heard.
-
Zealand announces confirmatory Phase III results in hypoglycaemia
pharmaceutical-technology
May 15, 2019
Copenhagen-based Zealand Pharma has announced positive results from a Phase III confirmatory study investigating dasiglucagon in patients with severe hypoglycaemia related to diabetes.
-
Researchers warn about gangrene cases in patients on SGLT2 diabetes drugs
fiercepharma
May 13, 2019
After the FDA last year slapped a warning label on SGLT2 diabetes drugs, detailing risks of an infection with a rare fle
-
EU approval for Sanofi’s type 2 diabetes treatment
europeanpharmaceuticalreview
May 08, 2019
Suliqua is an innovative new combination therapy that has the potential to address significant unmet needs for people living with type 2 diabetes in Europe
-
Newer Diabetes Drugs Linked to 'Flesh-Eating' Genital Infection
drugs
May 07, 2019
Newer Diabetes Drugs Linked to 'Flesh-Eating' Genital Infection.
-
Diabetes drug significantly reverses memory loss in Alzheimer’s disease
europeanpharmaceuticalreview
April 30, 2019
A drug developed for diabetes could be used to treat Alzheimer’s after scientists discover it significantly reversed memory loss in mice through a triple method of action…
-
Progress of Diabetes Treatment with TCM Compound Preparations
PharmaSources/Xiaonisha
April 26, 2019
Diabetes is an endocrine and metabolic disorder disease characterized by increase of plasma glucose level, and is called the three worldwide diseases together with cancers and cardiovascular diseases.